Pancreatic Cancer
CA240-0030 - A Randomized, Phase 2/3 Study Comparing BMS-986504 Combined with Gemcitabine and Nab-paclitaxel versus Gemcitabine and Nab-paclitaxel in Participants with Untreated Metastatic Pancreatic Ductal Adenocarcinoma Harboring Homozygous MTAP Deletion
- Details
ClinicalTrials.gov ID:
NCT07076121
Diagnosis Type:
NA
USOR Number:
- Address
,
P: